Data Year:

For its 2025 fiscal year, CONMED Corp, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2025
Name And Title Total Compensation Pay Rank By Title In MFG Durable industry
Patrick J. Beyer
President and Chief Executive Officer
Total Compensation $7,634,873 View details Pay Rank By Title In MFG Durable industry #283 View more
Todd W. Garner
Executive Vice President, Finance and Chief Financial Officer
Total Compensation $3,297,396 View details Pay Rank By Title In MFG Durable industry #207 View more
Brent Lalomia
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
Total Compensation $1,662,776 View details Pay Rank By Title In MFG Durable industry #197 View more
Peter K. Shagory
Executive Vice President, Strategy and Corporate Development
Total Compensation $1,563,789 View details Pay Rank By Title In MFG Durable industry #206 View more
Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Total Compensation $1,842,776 View details Pay Rank By Title In MFG Durable industry #103 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at CONMED Corp as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. CONMED Corp income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. CONMED Corp annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Patrick J. Beyer
President and Chief Executive Officer
Total Cash $2,020,569 Equity $4,999,948 Other $614,356 $7,634,873
Todd W. Garner
Executive Vice President, Finance and Chief Financial Officer
Total Cash $1,269,354 Equity $2,000,086 Other $27,956 $3,297,396
Brent Lalomia
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
Total Cash $750,572 Equity $874,959 Other $37,245 $1,662,776
Peter K. Shagory
Executive Vice President, Strategy and Corporate Development
Total Cash $706,492 Equity $850,033 Other $7,264 $1,563,789
Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Total Cash $835,659 Equity $1,000,012 Other $7,105 $1,842,776
For its 2025 fiscal year, CONMED Corp, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Patrick J. Beyer CEO Pay $7,634,873 Median Employee Pay $50,348 CEO Pay Ratio 152:1
For its 2024 fiscal year, CONMED Corp, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Barbara J. Schwarzentraub Total Cash $344,445
Brian P. Concannon Total Cash $319,766
Charles M. Farkas Total Cash $270,393
David Bronson Total Cash $329,945
Jerome J. Lande Total Cash $36,831
John L. Workman Total Cash $278,229
LaVerne Council Total Cash $276,822
Martha Goldberg Aronson Total Cash $358,072
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.